Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.

Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.

Item
http://www.wikidata.org/entity/Q33374678
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2Diverse mechanisms of AKT pathway activation in human malignancyA multi-shRNA vector enhances the silencing efficiency of exogenous and endogenous genes in human cells.Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancerExpression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancerAplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer.Oncogenes associated with drug resistance in ovarian cancer.BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines.TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro.Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
P2860

Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.

Item
http://www.wikidata.org/entity/Q33374678
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Implication of the Akt2/surviv ...... in human ovarian cancer cells.
@ast
Implication of the Akt2/surviv ...... in human ovarian cancer cells.
@en
type
label
Implication of the Akt2/surviv ...... in human ovarian cancer cells.
@ast
Implication of the Akt2/surviv ...... in human ovarian cancer cells.
@en
prefLabel
Implication of the Akt2/surviv ...... in human ovarian cancer cells.
@ast
Implication of the Akt2/surviv ...... in human ovarian cancer cells.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Implication of the Akt2/surviv ...... in human ovarian cancer cells.
@en
P2093
P304
P31
P356
10.1016/J.CANLET.2008.08.027
P407
P433
P478
P50
P577
P698
P921